Our data reinforce the importance of frequently observed mutations at positions corresponding to FGFR3 N540 and K650 that occur in different FGFRs and in a range of cancer types as well as in bone dysplasia (Figures 1–3, Supplementary Table S1) [7, 9, 24]. This evidence concerns the gene FGFR3 and cancer.